China Medical System says Dermavon gets NMPA approval for Lumirix NDA
China Medical System Holdings Limited says Dermavon received NMPA approval for its Lumirix NDA for atopic dermatitis.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.